Events

Sentinel Oncology will be participating in the following events

 

19th - 23rd October 2013

EORTC / NCI - Boston

 

7th - 9th November 2013

EORTC - Brussels   

 


 

Contact details

Sentinel Oncology Limited
23 Cambridge Science Park
Milton Road
Cambridge
UK
CB4 0EY

 

Tel: +44(0)1223 437123
Fax: +44(0)1223 437125

 

General enquiries: info@sentineloncology.com

Investors & Partnering: busdev@sentineloncology.com


Welcome to Sentinel Oncology

 

Sentinel Oncology Limited is committed to the discovery of new and innovate treatments for cancer patients. We are passionate about advancing novel ideas for new cancer drugs from concept to candidate drug selection....more

 

Our R&D is focused on the development of targeted therapeutics for areas of unmet medical need in oncology....more

 

  


 

Latest news & press releases

May 2013

Sentinel Oncology achieves milestone in Horizon Discovery agreement

Cambridge, UK, 8th May 2013: Sentinel Oncology (Sentinel) today announced it has achieved a research milestone in its collaboration… read more

March 2013

Sentinel Oncology begin Discovery Collaboration with Professor Anthony Chalmers

Sentinel Oncology Limited (Sentinel) is pleased to announce the start of a collaboration with Professor Anthony Chalmers… read more

November 2012

Sentinel Oncology awarded Biomedical Catalyst funding to develop cancer drug

Sentinel Oncology is pleased to announce that it was recently awarded an Early Stage grant as part of the government-backed… read more